{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:58:15Z","timestamp":1759366695458,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijmmb.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T04:02:50Z","timestamp":1610510570000},"page":"63-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and immunogenicity of SURE RAB\u2122, an inactivated cell culture derived rabies vaccine: A comparative, phase III clinical trial"],"prefix":"10.1016","volume":"39","author":[{"given":"Atul","family":"Kakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Gogia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay Kumar","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjit","family":"Jadiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2021.01.001_bib1","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.20546\/ijcmas.2017.612.237","article-title":"Review on rabies and vaccines","volume":"6","author":"Abraham","year":"2017","journal-title":"Int J Curr Microbiol App Sci"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0255-0857(21)02707-9","article-title":"Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine","volume":"23","author":"Chhabra","year":"2005","journal-title":"Indian J. Med. Microbiol."},{"year":"1996","series-title":"Laboratory Techniques in Rabies","author":"Meslin","key":"10.1016\/j.ijmmb.2021.01.001_bib3"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3201\/eid1904.120185","article-title":"Discrepancies in data reporting for rabies, Africa","volume":"19","author":"Nel","year":"2013","journal-title":"Emerg. Infect. Dis."},{"year":"2003","series-title":"Assessing Burden of Rabies in India WHO Sponsored National Multi-Centric Survey","author":"Sudershan","key":"10.1016\/j.ijmmb.2021.01.001_bib5"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2012.04592.x","article-title":"Developments in rabies vaccines","volume":"169","author":"Hicks","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib7","unstructured":"Association for prevention and control of Rabies in India \u2013Bhubaneshwar, INDIA. Association for prevention and control of Rabies in India Available at URL:https:\/\/apcrijournalorg\/JournalPDF\/July2011pdf Last accessed on 12 June 2018 July 2011;."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib8","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper-recommendations","volume":"28","author":"Organization","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0264-410X(96)00314-3","article-title":"A\u00a0global review of rabies vaccines for human use","volume":"15","author":"Dreesen","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tmaid.2007.07.004","article-title":"Preventing rabies with the Verorab\u00ae vaccine: 1985\u20132005: twenty years of clinical experience","volume":"5","author":"Toovey","year":"2007","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.7326\/0003-4819-64-6-1297","article-title":"Human rabies after antiserum and vaccine postexposure treatment: case report and review","volume":"64","author":"Anderson","year":"1966","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib13","first-page":"375","article-title":"Elimination of human rabies in a canine endemic province in Thailand: five-year programme","volume":"81","author":"Kamoltham","year":"2003","journal-title":"Bull. World Health Organ."},{"issue":"4","key":"10.1016\/j.ijmmb.2021.01.001_bib14","first-page":"115","article-title":"Safety and immunogenicity of rabies vaccine sure RAB TM (BIOMED) and VERORAB TM (SANOFI PASTEUR)","volume":"5","author":"Garg","year":"2012","journal-title":"Biotechnol. Int."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/21645515.2015.1048938","article-title":"Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases","volume":"11","author":"Narayana","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijmmb.2021.01.001_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2004.02103.x","article-title":"The revision of the Declaration of Helsinki: past, present and future","volume":"57","author":"Carlson","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"year":"2013","series-title":"WHO Expert Consultation on Rabies: Second Report","author":"Organization","key":"10.1016\/j.ijmmb.2021.01.001_bib18"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib19","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.vaccine.2005.03.007","article-title":"Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine","volume":"23","author":"Beran","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmmb.2021.01.001_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(84)92286-4","article-title":"A\u00a0new, highly immunogenic duck embryo rabies vaccine","volume":"323","author":"Gl\u00fcck","year":"1984","journal-title":"Lancet"},{"year":"2005","series-title":"WHO Expert Consultation on Rabies: First Report","author":"Organization","key":"10.1016\/j.ijmmb.2021.01.001_bib21"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:17:49Z","timestamp":1759346269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0255085721000013"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2021.01.001","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of SURE RAB\u2122, an inactivated cell culture derived rabies vaccine: A comparative, phase III clinical trial","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}